Wednesday, May 6, 2009

"Orphan or designer" drug poll

Should "orphan or designer" drugs be manufactured and made available to those who suffer rare diseases?


I think it is an ethical imperative for the megadollar drug companies to perform research and development and distribution of "orphan or designer" drugs for the treatment and quality of life improvement of those stricken with rare diseases; they have the resources and it is their moral obligation to cure or ease suffering.

No comments: